Tooth agenesis may originate from either genetic or environmental factors. Genetically determined hypodontic disorders appear as isolated features or as part of a syndrome. Msx1, Pax9, and Axin2 are involved in non-syndromic hypodontia, while genes such as Shh, Pitx2, Irf6, and p63 are considered to participate in syndromic genetic disorders, which include tooth agenesis. In dentistry, artificial tooth implants represent a common solution to tooth loss problems; however, molecular dentistry offers promising solutions for the future. In this paper, the genetic and molecular bases of non-syndromic and syndromic hypodontia are reviewed, and the advantages and disadvantages of tissue engineering in the clinical treatment of tooth agenesis are discussed.
Get full access to this article
View all access options for this article.
References
1.
Adell R, Eriksson B, Lekholm U, Brånemark PI, Jemt T -1990-. Long-term follow-up study of osseointegrated implants in the treatment of totally edentulous jaws. Int J Oral Maxillofac Implants5:347–359.
2.
Bartlett D -2007-. Implants for life? A critical review of implant-supported restorations. J Dent35:768–772.
3.
Baum BJ, Mooney DJ -2000-. The impact of tissue engineering on dentistry. J Am Dent Assoc131:309–318.
4.
Brook AH -1984-. A unifying aetiological explanation for anomalies of human tooth number and size. Arch Oral Biol29:373–378.
5.
Bustos T, Simosa V, Pinto-Cisternas J, Abramovits W, Jolay L, Rodriguez L, et al. -1991-. Autosomal recessive ectodermal dysplasia: I. An undescribed dysplasia/malformation syndrome. Am J Med Genet41:398–404.
6.
Callan DP -2007-. Dental implant design and oral and systemic health. Compend Contin Educ Dent28:482–492.
7.
Chari NS, McDonnell TJ -2007-. The sonic hedgehog signaling network in development and neoplasia. Adv Anat Pathol14:344–352.
8.
Chishti MS, Muhammad D, Haider M, Ahmad W -2006-. A novel missense mutation in MSX1 underlies autosomal recessive oligodontia with associated dental anomalies in Pakistani families. J Hum Genet51:872–878.
9.
Choonara SA -2005-. Orthodontic space maintenance – a review of current concepts and methods. S Afr Dent J60:115–117.
10.
De Muynck S, Schollen E, Matthijs G, Verdonck A, Devriendt K, Carels C -2004-. A novel MSX1 mutation in hypodontia. Am J Med Genet A128:401–403.
11.
Dewinter G, Quirynen M, Heidbüchel K, Verdonck A, Willems G, Carels C -2003-. Dental abnormalities, bone graft quality, and periodontal conditions in patients with unilateral cleft lip and palate at different phases of orthodontic treatment. Cleft Palate Craniofac J40:343–350.
12.
Dodson TB -2006-. Predictors of dental implant survival. J MA Dent Soc54:34–38.
13.
Drozdzowska B, Pluskiewicz W, Michno M -2006-. Tooth count in elderly women in relation to their skeletal status. Maturitas55:126–131.
14.
Duailibi MT, Duailibi SE, Young CS, Bartlett JD, Vacanti JP, Yelick PC -2004-. Bioengineered teeth from cultured rat tooth bud cells. J Dent Res83:523–528.
15.
Fleischmannová J, Matalová E, Tucker AS, Sharpe PT -2008-. Mouse models of tooth abnormalities. Eur J Oral Sci116:1–10.
16.
Gabris K, Tarjan I, Csiki P, Konrad F, Szadeczky B, Rozsa N -2001-. [Prevalence of congenital hypodontia in the permanent dentition and its treatment.] Fogorv Sz94:137–140 -article in Hungarian-.
17.
Gracco A, Luca L, Siciliani G -2007-. Molar distalisation with skeletal anchorage. Aust Orthod J23:147–152.
18.
Grusovin M, Coulthard P, Jourabchian E, Worthington H, Esposito M -2008-. Intervention for replacing missing teeth: maintaining and recovering soft tissue health around dental implants. Cochrane Database Syst Rev23:CD003069.
19.
Harada H, Mitsuyasu T, Toyono T, Toyshima K -2002-. Epithelial stem cells in teeth. Odontology90:1–6.
20.
Hardcastle Z, Mo R, Hui CC, Sharpe PT -1998-. The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants. Development125:2803–2811.
21.
Headon DJ, Emmal SA, Ferguson BM, Tucker AS, Justice MJ, Sharpe PT, et al. -2001-. Gene defect in ectodermal dysplasia implicates a death domain adapter in development. Nature414:913–916.
22.
Hu B, Nadiri A, Kuchler-Bopp S, Perrin-Schmitt F, Peters H, Lesot H -2006-. Tissue engineering of tooth crown, root, and periodontium. Tissue Eng12:2069–2075.
23.
Hu G, Vastardis H, Bendall AJ, Wang Z, Logan M, Zhang H, et al. -1998-. Haploinsufficiency of MSX1: a mechanism for selective tooth agenesis. Mol Cell Biol18:6044–6051.
24.
Hwang SJ, Beaty TH, Panny SR, Street NA, Joseph JM, Gordon S, et al. -1995-. Association study of transforming growth factor alpha -TGF alpha- TaqI polymorphism and oral clefts: indication of gene-environment interaction in a population-based sample of infants with birth defects. Am J Epidemiol141:629–636.
25.
Jezewski PA, Vieira AR, Nishimura C, Ludwig B, Johnson M, O’Brien SE, et al. -2003-. Complete sequencing shows a role for MSX1 in non-syndromic cleft lip and palate. J Med Genet40:399–407.
26.
Jonsson T, Sigurdsson TJ -2004-. Autotransplantation of premolars to premolar sites. A long-term follow-up study of 40 consecutive patients. Am J Orthod Dentofacial Orthop125:668–675.
27.
Jumlongras D, Bei M, Stimson JM, Wang WF, DePalma SR, Seidman CE, et al. -2001-. A nonsense mutation in MSX1 causes Witkop syndrome. Am J Hum Genet69:67–74.
Kaste SC, Hopkins KP, Jones D, Crom D, Greenwald CA, Santana VM -1997-. Dental abnormalities in children treated for acute lymphoblastic leukemia. Leukemia11:792–796.
31.
Kere J, Srivastava AK, Montonen O, Zonana J, Thomas N, Ferguson B, et al. -1996-. X-linked anhidrotic -hypohidrotic- ectodermal dysplasia is caused by mutation in a novel transmembrane protein. Nat Genet13:409–416.
32.
Kim JW, Simmer JP, Lin BP, Hu JC -2006-. Novel MSX1 frameshift causes autosomal-dominant oligodontia. J Dent Res85:267–271.
33.
Kobielak A, Kobielak K, Wisniewski AS, Mostowska A, Biedziak B, Trzeciak WH -2001-. The novel polymorphic variants within the paired box of the PAX9 gene are associated with selective tooth agenesis. Folia Histochem Cytobiol39:111–112.
34.
Lammi L, Arte S, Somer M, Jarvinen H, Lahermo P, Thesleff I, et al. -2004-. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet74:1043–1050.
35.
Lexner MO, Bardow A, Hertz JM, Nielsen LA, Kreiborg S -2007-. Anomalies of tooth formation in hypohidrotic ectodermal dysplasia. Int J Paediatr Dent17:10–18.
36.
Lidral AC, Reising BC -2002-. The role of MSX1 in human tooth agenesis. J Dent Res81:274–278.
37.
Lin CR, Kioussi C, O’Connell S, Briata P, Szeto D, Liu F, et al. -1999-. Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature401:279–282.
38.
Lu MF, Pressman C, Dyer R, Johnson RL, Martin JF -1999-. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature401:276–278.
39.
Mao JJ, Giannobile WV, Helms JA, Holister SJ, Krebsbach PH, Longaker MT, et al. -2006-. Craniofacial tissue engineering by stem cells. J Dent Res85:966–979.
40.
Marec-Berard P, Azzi D, Chaux-Bodard AG, Lagrange H, Gourmet R, Bergeron C -2005-. Long-term effect of chemotherapy on dental status in children treated for nephroblastoma. Pediatr Hematol Oncol22:581–588.
41.
Mensah JK, Ogawa T, Kapadia H, Cavender AC, D’Souza RN -2004-. Functional analysis of a mutation in PAX9 associated with familial tooth agenesis in humans. J Biol Chem279:5924–5933.
42.
Monreal AW, Ferguson BM, Headon DJ, Street SL, Overbeek PA, Zonana J -1999-. Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia. Nat Genet22:366–369.
43.
Morra M -2007-. Biomolecular modification of implant surfaces. Exp Rev Med Dev4:361–372.
44.
Mostowska A, Biedziak B, Jagodzinski PP -2006-. Axis inhibition protein 2 -AXIN2- polymorphisms may be a risk factor for selective tooth agenesis. J Hum Genet51:262–266.
45.
Mucchielli ML, Mitsiadis TA, Raffo S, Brunet JF, Proust JP, Goridis C -1997-. Mouse Otlx2/RIEG expression in the odontogenic epithelium precedes tooth initiation and requires mesenchyme-derived signals for its maintenance. Dev Biol189:275–284.
46.
Nakahara T, Ide Y -2007-. Tooth regeneration: implication for the use of bioengineered organs in first-wave organ replacement. Hum Cell20:63–70.
47.
Nowzari H, Yi K, Chee W, Rich SK -2008-. Immunology, microbiology, and virology following placement of NobelPerfecttrade scalloped dental implants: analysis of a case series. Clin Implant Dent Res -E-print- -in press-.
48.
Ogawa T, Kapadia H, Wang B, D’Souza RN -2005-. Studies on Pax9-Msx1 protein interactions. Arch Oral Biol50:141–145.
49.
Ohazama A, Modino SA, Miletich I, Sharpe PT -2004-. Stem-cell-based tissue engineering of murine teeth. J Dent Res83:518–522.
50.
Peck L, Peck S, Attia Y -1993-. Maxillary canine-first premolar transposition, associated dental anomalies and genetic basis. Angle Orthod63:99–109.
51.
Pereira TV, Salzano FM, Mostowska A, Trzeciak WH, Ruiz-Linares A, Chies JA, et al. -2006-. Natural selection and molecular evolution in primate PAX9 gene, a major determinant of tooth development. Proc Natl Acad Sci USA103:5676–5681.
52.
Prager TM, Finke C, Miethke RR -2006-. Dental findings in patients with ectodermal dysplasia. J Orofac Orthop67:347–355.
53.
Radhakrishna U, Bornholdt D, Scott HS, Patel UC, Rossier C, Engel H, et al. -1999-. The phenotypic spectrum of GLI3 morphopathies includes autosomal dominant preaxial polydactyly type-IV and postaxial polydactyly type-A/B; no phenotype prediction from the position of GLI3 mutations. Am J Hum Genet65:645–655.
54.
Riise R, Storhaug K, Brøndum-Nielsen K -2001-. Rieger syndrome is associated with PAX6 deletion. Acta Ophthalmol Scand79:201–203.
55.
Schalk-van der Weide Y, Steen WH, Bosman F -1992-. Distribution of missing teeth and tooth morphology in patients with oligodontia. ASDC J Dent Child59:133–140.
56.
Scheideler L, Rupp F, Wendel HP, Sathe S, Geis-Gerstorfer J -2007-. Photocoupling of fibronectin to titanium surfaces influences keratinocytes adhesion, pellicle formation and thrombogenicity. Dent Mater23:469–478.
57.
Schwartz AB, Larson EL -2007-. Antibiotic prophylaxis and postoperative complications after tooth extraction and implant placement: a review of literature. J Dent35:881–888.
58.
Shapira Y, Lubit E, Kuftinec MM -2000-. Hypodontia in children with various types of clefts. Angle Orthod70:16–21.
59.
Shiang R, Lidral AC, Ardinger HH, Buetow KH, Romitti PA, Munger RG, et al. -1993-. Association of transforming growth-factor alpha gene polymorphisms with nonsyndromic cleft palate only -CPO-. Am J Hum Genet53:836–843.
60.
Slayton RL, Williams L, Murray JC, Wheeler JJ, Lidral AC, Nishimura CJ -2003-. Genetic association studies of cleft lip and/or palate with hypodontia outside the cleft region. Cleft Palate Craniofac J40:274–279.
61.
Steigmann M, Cooke J, Wang HL -2007-. Use of the natural tooth for soft tissue development: a case series. Int J Periodontics Restorative Dent27:603–608.
62.
Stimson JM, Sivers JE, Hlava GL -1997-. Features of oligodontia in three generations. J Clin Pediatr Dent21:269–275.
63.
Stockton DW, Das P, Goldenberg M, D’Souza RN, Patel PI -2000-. Mutation of PAX9 is associated with oligodontia. Nat Genet24:18–19.
64.
Suarez BK, Spence MA -1974-. The genetics of hypodontia. J Dent Res53:781–785.
65.
Suzuki Y, Jezewski PA, Machida J, Watanabe Y, Shi M, Cooper ME, et al. -2004-. In a Vietnamese population, MSX1 variants contribute to cleft lip and palate. Genet Med6:117–125.
66.
Symons AL, Stritzel F, Stamation J -1993-. Anomalies associated with hypodontia of the permanent lateral incisor and second premolar. J Clin Pediatr Dent17:109–111.
67.
Taba M Jr, Jin Q, Sugai JV, Giannobile WV -2005-. Current concepts in periodontal bioengineering. Orthod Craniofac Res8:292–302.
68.
Thilander B, Õdman J, Lekholm U -2001-. Orthodontic aspects of the use of oral implants in adolescents: a 10-year follow-up study. Eur J Orthod23:715–731.
69.
van den Boogaard MJH, Dorland M, Beemer FA, van Amstel HK -2000-. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet24:342–343. Erratum in Nat Genet 25:125, 2000.
70.
van Steenberghe D, Naert I, Jacobs R, Quirynen M -1999-. Influence of inflammatory reactions vs. occlusal loading on peri-implant marginal bone level. Adv Dent Res13:130–135.
71.
Vastardis H -2000-. The genetics of human tooth agenesis: new discoveries for understanding dental anomalies. Am J Orthod Dentofac Orthop117:650–656.
72.
Vastardis H, Karimbux N, Guthua SW, Seidman JG, Seidman CE -1996-. A human MSX1 homeodomain missense mutation causes selective tooth agenesis. Nat Genet13:417–421.
73.
Vieira AR, Meira R, Modesto A, Murray JC -2004-. MSX1, PAX9, and TGFA contribute to tooth agenesis in humans. J Dent Res83:723–727.
74.
Vieira AR, Modesto A, Meira R, Barbosa AR, Lidral AC, Murray JC -2007-. Interferon regulatory factor 6 -IRF6- and fibroblast growth factor receptor 1 -FGFR1- contribute to human tooth agenesis. Am J Med Genet A143:538–545.
75.
Yen AH, Sharpe PT -2006-. Regeneration of teeth using stem cell-based tissue engineering. Expert Opin Biol Ther6:9–16.
76.
Young CS, Abukawa H, Asrican R, Ravens M, Troulis MJ, Kaban LB, et al. -2005-. Tissue-engineered hybrid tooth and bone. Tissue Eng11:1599–1610.
77.
Young KA, Melrose CA, Harrison JE -2007-. Skeletal anchorage systems in orthodontics: absolute anchorage. A dream or reality? J Orthod34:101–110.
78.
Zhang H, Hu G, Wang H, Sciavolino P, Iler N, Shen MM, et al. -1997-. Heterodimerization of Msx and Dlx homeoproteins results in functional antagonism. Mol Cell Biol17:2920–2932.
79.
Zlotogora J -1994-. Syndactyly, ectodermal dysplasia, and cleft lip/palate. J Med Genet31:957–959.
80.
Zonana J, Elder ME, Schneider LC, Orlow SJ, Moss C, Golabi M, et al. -2000-. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-gamma -NEMO-. Am J Hum Genet67:1555–1562.
